Infant Formula Requirements

Forms and Documents

Document Name	Status
Form Form FDA 3978 Reports under FFDCA section 412(d) Form and Instruction	Unchanged
Form Form FDA 3978 New Infant Formula Submission Form and Instruction	Unchanged
Form Form FDA 3978 New Infant Formula Registration Form and Instruction	Modified
Form Form FDA 3978 Requirements for Quality Factors -- PER Exemption Form and Instruction	Unchanged
Form Form FDA 3978 Requirements for Quality Factors GMS Exemption Form and Instruction	Unchanged
Form Form FDA 3978 Exempt Infant Formula; Notification Requirements Form and Instruction	Modified
Form Form FDA 3978 Reports for exampt Infant Formula Form and Instruction	Unchanged
Form Form FDA 3978 Notifications under 106.120(b) Form and Instruction	Unchanged
0256 Infant Formula Requirements SSA 2021 EXT.docx Supporting Statement A	2021-04-23

IC Document Collections

IC ID	Document Title	Status
5835	Reports under FFDCA section 412(d) Form and Instruction	Unchanged
235376	Exempt Infant Formula Production; GMP; Audits, Records & Records Other-Agency Guidance	Modified
212199	Part 106; Subpart B - CGMP Requirements (records)	Unchanged
212198	New Infant Formula Submission Form and Instruction	Unchanged
212197	New Infant Formula Registration Form and Instruction	Modified
212196	Requirements for Quality Factors -- PER Exemption Form and Instruction	Unchanged
212194	Requirements for Quality Factors GMS Exemption Form and Instruction	Unchanged
179355	Infant Formula; Labeling (3rd Party Disclosure) Requirements	Unchanged
179354	Recordkeeping under Part 106; Subparts C-G - quality control, audits, testing, records	Unchanged
179353	Part 107; Subpart C - Exempt Infant Formulas (records)	Unchanged
179352	Exempt Infant Formula; Notification Requirements Form and Instruction	Modified
179351	Reports for exampt Infant Formula Form and Instruction	Unchanged
179350	Notifications under 106.120(b) Form and Instruction	Unchanged

ICR Details

OMB Control No: 0910-0256	ICR Reference No: 202104-0910-013
Status: Received in OIRA	Previous ICR Reference No: 201903-0910-014
Agency/Subagency: HHS/FDA	Agency Tracking No: CFSAN
Title: Infant Formula Requirements
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 04/23/2021

	Requested	Previously Approved
Expiration Date	36 Months From Approved	05/31/2021
Responses	7,995	7,997
Time Burden (Hours)	128,530	128,838
Cost Burden (Dollars)	0	0

---

Abstract: This ICR supports the recordkeeping, reporting, and labeling requirements for the manufacture and distribution of infant formula. Respondents to this collection are infant formula manufacturers who must ensure that their products adhere to the quality control provisions and procedures found in FDA regulations, and that nutrient information and directions for use are disclosed in their product labeling.

---

Authorizing Statute(s): US Code: 21 USC 301 et seq. Name of Law: Federal Food, Drug, and Cosmetic Act (FFDCA)
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 77469	12/02/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 21754	04/23/2021
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 13

IC Title	Form No.	Form Name
Exempt Infant Formula Production; GMP; Audits, Records & Records
Exempt Infant Formula; Notification Requirements	Form FDA 3978	Infant Formula Tracking System
Infant Formula; Labeling (3rd Party Disclosure) Requirements
New Infant Formula Registration	Form FDA 3978	Infant Formula Tracking System
New Infant Formula Submission	Form FDA 3978	Infant Formula Tracking System
Notifications under 106.120(b)	Form FDA 3978	Infant Formula Tracking System
Part 106; Subpart B - CGMP Requirements (records)
Part 107; Subpart C - Exempt Infant Formulas (records)
Recordkeeping under Part 106; Subparts C-G - quality control, audits, testing, records
Reports for exampt Infant Formula	Form FDA 3978	Infant Formula Tracking System
Reports under FFDCA section 412(d)	Form FDA 3978	Infant Formula Tracking System
Requirements for Quality Factors -- PER Exemption	Form FDA 3978	Infant Formula Tracking System
Requirements for Quality Factors GMS Exemption	Form FDA 3978	Infant Formula Tracking System

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	7,995	7,997	0	0	-2	0
Annual Time Burden (Hours)	128,530	128,838	0	0	-308	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Based on a review of this information collection since our last request for OMB approval, we have made no adjustments. However, we corrected a nominal calculation error which results in a decrease of 2 responses and 308 hours annually.

---

Annual Cost to Federal Government: $1,049,187

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 04/23/2021

---